VirTrial increases global presence with telemedicine platform

5th February 2020 (Last Updated February 5th, 2020 15:20)

Clinical trials technology provider VirTrial has announced its expansion internationally with the fully scalable telemedicine platform.

Clinical trials technology provider VirTrial has announced its expansion internationally with the fully scalable telemedicine platform.

VirTrial has achieved a network of virtual trial capable research sites in 31 countries.

The Virtual Care Management (VCM) telemedicine platform is a mobile application and web interface. The product has been improved with features that support language translation into any left to right reading language.

The VCM platform is compliant with the Health Insurance Portability and Accountability Act (HIPAA), Health Information Technology for Economic and Clinical Health (HITECH) Act, and Privacy Shield.

VirTrial has implemented policies that support General Data Protection Regulation (GDPR) compliance.

VirTrial CEO Mark Hanley said: “Clinical research requires collaboration at a global level and the ability to recruit a diverse representation of patients from around the world.

“Our VCM platform and network of trained research professionals provide a unique opportunity for sponsors and CROs to develop more expansive studies than what has been possible in the past.”

The company recently appointed Emil Hoeck as international director of business development.

In October last year, VirTrial formed an alliance to enable virtual clinical trials at Pratia clinical research centres in Europe.

In the same year, the company partnered with the Association of Clinical Research Professionals (ACRP) to provide a training and certificate programme to all domestic and abroad members of ACRP.

The company has so far certified over 1,000 clinical research professionals across 31 countries.